Key Players are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Agilent Technologies Inc. (U.S.)
(PRWEB) February 20, 2015
The number of factors such as growing geriatric population, technological advancements, rising incidence of infectious diseases, increased public-private investments and funds are driving the growth of the global digital PCR and qPCR market.
Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=174151204
As of 2014 North America holds the largest share of the digital PCR and qPCR market followed by Europe. However the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. A number of factors such as increased awareness related to gene-based disease diagnosis and treatment, growing public and private support to develop novel dPCR and qPCR technologies, rise of Indian genomics market and strengthening cancer research in Japan increasing focus of global life science companies in emerging markets are stimulating the growth of the digital PCR and qPCR market in the Asia-Pacific region.
As of 2013 Thermo Fisher Scientific Inc. (U.S.) held the leadership position in the global digital PCR and qPCR market. Over the past three years, the company adopted new product launches, product enhancements, geographic expansions and strategic acquisitions as its key business strategies to ensure its dominant position in this market.
MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 full time analysts and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, and identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology